1-3 of 3
Kengo Yamawaki
Close
Sort by
Journal Articles

First Preclinical Report of the Efficacy and PD Results of KHK2823, a Non-Fucosylated Fully Human Monoclonal Antibody Against IL-3Rα

Tadakazu Akiyama, PhD, Shin-ichiro Takayanagi, PhD, Yoshimi Maekawa, Kohta Miyawaki, MD, Fumiaki Jinnouchi, MD, Takashi Jiromaru, MD, Takeshi Sugio, MD, Shinya Daitoku, MD, Hirotake Kusumoto, MD, Munetake Shimabe, PhD, Satoshi Nishikawa, Kengo Yamawaki, Kousuke Iijima, Masanori Hiura, Takeshi Takahashi, PhD, Yoshikane Kikushige, MD PhD, Hiromi Iwasaki, MD PhD, Koichi Akashi, MD PhD, Tomonori Tawara, PhD
Journal: Blood
Blood (2015) 126 (23): 1349.
https://doi.org/10.1182/blood.V126.23.1349.1349
Published: 2015
Journal Articles

Osteoblast Stimulating Factor-5 Regulates B Lymphopoiesis Via Inhibiting Pre B Cell Proliferation

Natsuko Fujita, Kenji Oritani, Michiko Ichii, Norimitsu Saitoh, Kengo Yamawaki, Kazuma Tomizuka, Yuzuru Kanakura
Journal: Blood
Blood (2014) 124 (21): 2926.
https://doi.org/10.1182/blood.V124.21.2926.2926
Published: 2014
Journal Articles

SFRP5 Inhibits Early Stages Of B-Cell Differentiation and Modulates Estrogen-Related Changes In The Immune System

Takafumi Yokota, Kenji Oritani, Takao Sudo, Tomohiko Ishibashi, Yukiko Doi, Yoko Habuchi, Michiko Ichii, Daisuke Okuzaki, Kazuma Tomizuka, Kengo Yamawaki, Akihiko Shimono, Eiichi Morii, Paul W. Kincade, Yuzuru Kanakura
Journal: Blood
Blood (2013) 122 (21): 2422.
https://doi.org/10.1182/blood.V122.21.2422.2422
Published: 2013